Skip to content
Menu

Inhibrx Biosciences, Inc. INBX

Full chart Compare
Set alert

Price alert · INBX

All alert types
74.18 USD -3.48 (-4.48%)

Regular-session close

74.18 0.00 0.00%

After hours · Nov 17, 4:00 PM ET

72.95 Day range 78.21
57.30 52-week range 155.29
YTD
-6.10%
1 year
-4.10%

Revenue & Expenses

Revenue Profit Costs
Other Operating Income$2.48MNet Loss$140.06MCost of Revenue$2.48MExpenses$142.54MGross Loss$1.18MSelling, General & Admin$23.30MResearch & Development$113.03MOther Expenses$5.03MIncome Tax$2.00KRevenue$1.30M

Latest period ending Dec 31, 2025 · select a line to chart its full history

INBX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.30M200.00K1.80M2.19M7.23M
1.30M200.00K1.80M2.19M7.23M
-135.03M-331.45M-219.22M-129.12M-76.56M
-140.06M1.69B-241.36M-145.23M-81.77M
-9.04112.62-20.48-3.62-2.15
INBX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
124.22M152.60M277.92M273.87M131.30M
146.48M180.77M307.89M290.88M150.45M
138.49M47.18M264.39M232.82M98.07M
107.01M8.05M210.14M207.10M77.18M
7.99M133.58M43.50M58.06M52.38M
INBX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-129.79M-194.41M-193.31M-115.30M-80.32M
-28.00K-2.60M-4.59M-686.00K-809.00K
101.45M71.68M201.96M258.55M83.77M
-28.00K-2.60M-4.59M-686.00K-809.00K
-28.38M-125.33M4.06M142.56M2.64M